✦ LIBER ✦

A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma

✍ Scribed by Ivana N. M. Micallef; Brad S. Kahl; Matthew J. Maurer; Ahmet Dogan; Stephen M. Ansell; Joseph P. Colgan; Susan Geyer; David J. Inwards; William L. White; Thomas M. Habermann

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 122 KB
Volume: 107
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.22342

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity and safety of dose-adjusted inf

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

✍ Antonino Musolino; Daniela Boggiani; Michele Panebianco; Giovanna Vasini; Stefan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 1 views

Activity and safety of dose-adjusted inf

✍ Alberto Febbri; Alessandro Gozzetti; Luigi Rigacci 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Reply to activity and safety of dose-adj

Reply to activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

✍ Antonino Musolino; Daniela Boggiani; Michele Panebianco 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

Cost utility in the United States of rit

Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma

✍ John C. Hornberger; Jennie H. Best 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

Randomized comparison of cladribine alon

Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients : Final report of the Polish Lymphoma Research Group

✍ Ewa Kalinka-Warzocha; Jaroslaw Wajs; Ewa Lech-Maranda; Bernadetta Ceglarek; Jerz 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

Combination of rituximab with chemothera

Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication

✍ Hervé Ghesquières; Céline Ferlay; Catherine Sebban; Catherine Chassagne; Liana C 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

## Abstract Randomized trials have demonstrated improved outcome from adding rituximab to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) for patients with diffuse large B‐cell lymphoma (DLBCL). This retrospective study compared the outcomes of 224 patients with DLBCL treated in our i